Model 436-01 Biopore Implantable Pacing Lead
by Intermedics, Inc. 510(k)
Active
510(k) K862051
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK862051 | Date6 Jan 1987 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Model 436-01 Biopore Implantable Pacing Lead is a permanent pacemaker electrode, classified under the nomenclature for cardiovascular devices. It is designed for transvenous implantation to deliver electrical pacing stimuli to the heart, supporting cardiac rhythm regulation in patients with bradycardia or conduction disorders.
This device is supplied sterile and intended for single-use implantation. It is regulated under FDA 510(k) clearance (K862051) as a Class III medical device (product code DTB) and is intended for use in clinical settings by trained healthcare professionals. The lead is compatible with MRI environments under specific conditions as outlined in its labeling, though MRI safety parameters must be strictly adhered to. Storage requires adherence to manufacturer guidelines for sterile packaging integrity.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the primary clinical purpose of the Model 436-01 Biopore Implantable Pacing Lead, and how is it implanted?
The Model 436-01 Biopore Implantable Pacing Lead is designed to deliver electrical pacing stimuli to the heart for patients with bradycardia or conduction disorders. It is implanted transvenously, meaning it is inserted through a vein (typically the subclavian or jugular vein) and advanced into the heart chamber where pacing is required. This procedure is performed by trained healthcare professionals in a clinical setting.
Is the Model 436-01 Biopore Implantable Pacing Lead intended for reuse, or is it single-use only?
The Model 436-01 Biopore Implantable Pacing Lead is explicitly intended for single-use implantation only. It is supplied sterile and should not be reused after initial use to ensure patient safety and device efficacy.
How should the Model 436-01 Biopore Implantable Pacing Lead be stored, and what precautions should be taken?
The lead must be stored according to the manufacturer’s guidelines to maintain sterile packaging integrity. This includes keeping it in its original, unopened packaging, protecting it from physical damage, and ensuring it remains in a clean, dry environment. Avoid exposure to extreme temperatures or moisture, as these could compromise sterility or device performance.
Can this device be used in patients who require MRI scans, and if so, what conditions apply?
The Model 436-01 Biopore Implantable Pacing Lead is compatible with MRI environments under specific conditions, as outlined in its labeling. However, strict adherence to MRI safety parameters is required to prevent adverse events. Clinicians must follow the manufacturer’s guidelines and consult the device’s labeling for detailed MRI safety instructions before proceeding.
What regulatory pathway was followed for FDA clearance of this device, and what classification does it hold?
The Model 436-01 Biopore Implantable Pacing Lead was cleared through the FDA 510(k) pathway under the traditional review process, with a decision of *Substantially Equivalent* (SESE). It is classified as a Class III medical device under product code DTB, reflecting its role as a permanent pacemaker electrode for critical cardiac rhythm regulation. The clearance number is K862051.